Clinical Trials

Inclusion Criteria:

• Women who identify as Black or Hispanic.
• Women > 30 years old and < 75 years old.
• Women with any of the following:
  • IBIS (Tyrer-Cuzick) score for the lifetime risk ≥ 20%;
  • History of biopsy proven atypical ductal hyperplasia or atypical lobular hyperplasia;
  • History of biopsy proven lobular carcinoma in situ.
• Able to participate in all aspects of the study.
• Understand and signed the study informed consent.

Exclusion Criteria:

• Women whose lifetime risk for breast cancer falls below the threshold (< 20 % lifetime risk).
• Unable to give informed consent.
• Prior history of invasive breast cancer, ductal carcinoma in situ or other breast cancers.
• At high risk due to prior radiation therapy to the chest.
• Women who are pregnant or breastfeeding.
• Prior risk reducing or prophylactic mastectomy.

Eligibility last updated 4/7/22. Questions regarding updates should be directed to the study team contact.